Did you know?

Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than ...Zynex. 03 May, 2023, 16:01 ET. ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI ), today announced its intent to offer, subject to market conditions and other ...Zynex, Inc.(Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022.Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $48.81 million for the quarter ended December 2022, missing the Zacks Consensus Estimate by 1.69%. This ...Zynex Pro TLSO; OA Knee Brace; Zynex Pro Wrist Brace; Post-Op Knee Brace; Saunders Cervical Traction; ComforTrac Cervical Traction; Zynex CryoHeat; E …WebNov 13, 2023 · --Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today ... Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ...May 3, 2023 · ENGLEWOOD, Colo., May 3, 2023 /PRNewswire/ -- Zynex, Inc. ("Zynex") (Nasdaq: ZYXI), today announced its intent to offer, subject to market conditions and other factors, $50 million aggregate principal amount of its convertible senior notes due 2026 (the "Notes") in a private offering (the "Notes Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule ... We’ve been at it for more than 25 years, and we’re just getting started. Zynex, Inc. was founded by Thomas Sandgaard in 1996 to develop advanced electrotherapy technology that alleviates chronic pain and aids the recovery of patients affected by debilitating illnesses. Hayward Pool Products Inc has been a leader in the swimming pool industry for over 90 years. Founded in 1925, Hayward has been committed to providing innovative and high-quality products for residential and commercial pools.SafeAssign is an online plagiarism detection tool developed by Blackboard, Inc. It is designed to help instructors and students detect and prevent plagiarism in their academic work.Zynex, Inc. développe, fabrique, commercialise et vend des dispositifs médicaux utilisés pour le traitement de la douleur et la rééducation, ainsi que des ...About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ...Nov 15, 2023 · Zynex Inc. Stock Price History. Zynex Inc.’s price is currently down 0.68% so far this month. During the month of November, Zynex Inc.’s stock price has reached a high of $9.54 and a low of $8.68. Over the last year, Zynex Inc. has hit prices as high as $17.25 and as low as $6.88. Year to date, Zynex Inc.’s stock is down 2.69%. Aug 9, 2023 · Zynex. 09 Aug, 2023, 09:15 ET. ENGLEWOOD, Colo., Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ... 0.49%. $58.97M. ZYXI | Complete Zynex Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WebNov 15, 2023 · Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient... We’ve been at it for more than 25 years, and we’re jZynex, Inc. Common Stock (ZYXI) Stock Quotes - Nasdaq offers stock q The projected fair value for Zynex is US$10.27 based on 2 Stage Free Cash Flow to Equity. Zynex's US$8.23 share price indicates it is trading at similar levels as its fair value estimate. Today we ...Zynex Declares Special Cash Dividend of $0.10 Per Share and 10% Stock Dividend Thomas Sandgaard, CEO, Chairman and Founder said: "With our continued… Shared by Thomas Sandgaard ENGLEWOOD, Colo., April 19, 2023 / PRNewswir Zynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q3 2023 Earnings Conference Call October 26, 2023 4:15 PM ETCompany ParticipantsQuinn Callanan - Investor RelationsThomas...This report compares the performances of Zynex Inc. (ZYXI) and BioLife Solutions, Inc. (BLFS) stocks. After reading this report, you will learn the differences in growth, annual returns, dividend payouts, splits, biggest gains etc. The timeframe of analysis is between '11-26-2013' and '11-24-2023'. In total, there are 7 sections in this report. 1 Nov 2023 ... Zynex Inc. (ZYXI) is around the to

Mar 13, 2023 · About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser ... Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation ...Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than ...Nov 1, 2023 · Zynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than ... ENGLEWOOD, Colo., Oct. 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, October 26, 2023 at 4:15 PM Eastern Time to …

Item 1.01. Entry Into or Amendment of a Material Definitive Agreement. On May 4, 2023, Zynex, Inc. priced a private offering of $52,500,000 in aggregate principal amount of its 5.00% Convertible...--Zynex, Inc., an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Q3 2023 Revenue Increased 20% to $49.9 Million. Possible cause: Zynex. 15 Nov, 2023, 09:15 ET. ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Z.